Bahrt Kenneth
Insider CIK 1527197 · ONS Chief Medical Officer · SVNT SVP, Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-02-19 | 2019-02-19 | 600,000 | — | $0 | 600,000 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-10-22 | 2018-10-24 | 450,000 | — | $0 | 450,000 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2018-06-25 | 2018-06-27 | 7,700 | $0.85 | $6.5K | 47,120 | SEC↗ |
| ONS Oncobiologics, Inc. | S Sale | 2017-12-22 | 2017-12-26 | 26,165 | $1.13 | $29.6K | 54,820 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2016-12-21 | 2016-12-22 | 50,000 | — | $0 | 80,985 | SEC↗ |
| ONS Oncobiologics, Inc. | P Buy deriv | 2016-05-13 | 2016-05-17 | 1,000 | — | $0 | 1,000 | SEC↗ |
| ONS Oncobiologics, Inc. | P Buy deriv | 2016-05-13 | 2016-05-17 | 1,000 | — | $0 | 1,000 | SEC↗ |
| ONS Oncobiologics, Inc. | P Buy | 2016-05-13 | 2016-05-17 | 2,000 | — | $0 | 2,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-16 | 2013-10-17 | 3,500 | $0.07 | $245 | 102,900 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-16 | 2013-10-17 | 1,600 | $0.07 | $112 | 106,400 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-16 | 2013-10-17 | 2,400 | $0.07 | $168 | 100,500 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-16 | 2013-10-17 | 500 | $0.07 | $35 | 100,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 3,911 | $0.08 | $313 | 108,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 65,639 | $0.08 | $5.3K | 112,572 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-10-15 | 2013-10-17 | 661 | $0.08 | $53 | 111,911 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-04-30 | 2013-05-01 | 1,250 | $0.74 | $925 | 178,211 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2013-03-05 | 2013-03-07 | 90,000 | — | $0 | 90,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2013-03-05 | 2013-03-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2013-03-05 | 2013-03-07 | 110,000 | — | $0 | 110,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 21,700 | $1.04 | $22.6K | 171,750 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 7,300 | $1.01 | $7.4K | 193,450 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2013-01-31 | 2013-02-04 | 1,300 | $1.03 | $1.3K | 200,750 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2012-10-31 | 2012-11-06 | 1,000 | $1.45 | $1.4K | 202,050 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | S Sale | 2012-08-01 | 2012-08-03 | 4,950 | $0.62 | $3.1K | 203,050 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award deriv | 2012-02-01 | 2012-02-13 | 100,000 | $2.26 | $226.0K | 100,000 | SEC↗ |
| SVNT SAVIENT PHARMACEUTICALS IN | A Award | 2012-02-01 | 2012-02-13 | 150,000 | $2.26 | $339.0K | 208,000 | SEC↗ |